This topic contains a solution. Click here to go to the answer

Author Question: For a practitioner who works under a managed care system, clients have a right to know that: a. ... (Read 55 times)

Marty

  • Hero Member
  • *****
  • Posts: 553
For a practitioner who works under a managed care system, clients have a right to
  know that:
 
  a. they will have access to needed care that extends beyond their benefits.
  b. financial incentives exist to keep the amount or type of service limited.
  c. the number of sessions that are allowed will be determined by the type of therapy needed by the client.
  d. the system will have no access to their records.

Question 2

Educating clients about the treatment process might well include exploring:
 
  a. what services the therapist will provide.
  b. how long the will treatment last.
  c. the behavior expected of the client.
  d. what financial considerations need to be taken into account.
  e. all of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chjcharjto14

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

ANS: B

Answer to Question 2

ANS: E




Marty

  • Member
  • Posts: 553
Reply 2 on: Jul 30, 2018
Excellent


chereeb

  • Member
  • Posts: 326
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library